īayer is combining the Group’s digital health initiatives under the name G4A (formerly Grants4Apps). Upside Health: Upside Health has developed Ouchie, an app for chronic pain management through tools such as congnitive behavioral therapy, community support, pain tracking, education resources and integration with clinicians.BioLum Sciences (United States): Developer of the BioSense AMD – a point-of-care, low cost device that works with a proprietary biomarker technology to analyze airway inflammation.Visotec (Germany): At-home hand-held optical coherence tomography (OCT) for monitoring.Litesprite (USA): Litesprite creates games that combine medical treatment and engagement of mobile gaming to help patients proactively manage chronic health conditions such as stress, anxiety and depression.Wellthy Theapeutics (India): Wellthy Therapeutics has a clinically validated behavioral intervention platform to help people change their behaviors and reduce their risk of chronic disease.
NEUROTRACKER CUSTOMIZE SOFTWARE SOFTWARE
OKKO Health (United Kingdom): OKKO Health has developed a personalized smartphone software for accurate remote monitoring of visual health outside of ophthalmology clinics.RelianceHMO (Nigeria): A health insurance company using software, data science, and telemedicine to make health insurance affordable and easier to access.Carepay (Kenya): Carepay has a mobile health payment platform to send, save, and spend funds for healthcare.NeuroTracker (Canada): Cognitive training program designed to improve cognitive and mental performance.Blackford Analysis (United Kingdom): A curated marketplace platform of regulatory-approved medical image analysis apps and AI algorithms for clinical value add.Prevencio Med (United States): Blood based tests and algorithms to predict risk of cardiovascular diseases and events.Here, an initial project funding is followed by incremental milestone-based payments. Under the terms of the Advance Track, startups looking to co-create and execute commercial deals are supported. Mentoring and coaching by Bayer executives are also part of the program. Under the terms of the Growth Track, selected early-stage startups receive EUR 75.000 funding for co-creating products or solutions, as well as co-working space at Bayer’s Pharmaceuticals division headquarters in Berlin, Germany. The new program offers two different ways of collaboration with Bayer in the digital health space. Zsuzsanna Varga, who is heading the Bayer G4A Digital Health Partnerships program. “Our company’s “G4A Digital Health Partnerships” program paves the road for longer-term collaborations through which both parties can bring to market new solutions at the intersection of health and technology,” said Dr.
“We received a high number of very mature digital health startup applications and are excited to jointly develop and scale new digital solutions that will help benefit the health of our patients and consumers,” said Eugene Borukhovich, Head of Digital Health at Bayer. The participating healthcare startup companies were selected by Bayer from over 750 applications out of 65 countries based on the strategic fit, development stage of the project, and the assessment of internal experts. As part of the program, Bayer will support these startup companies aiming for longer-term collaborations to drive forward the development of specific digital solutions to improve patients’ health in the fields of cardiovascular diseases, oncology, ophthalmology, pulmonology, radiology as well as digital therapeutics. Looking for a job in an innovative company? Learn more about Bayer and the opportunities available.īerlin, Octo– Bayer announced today that the company has signed collaboration agreements with eleven digital health startups. Sustainability & Socially Responsible Investing.Countermotions & Proposals for Election.This area provides news, videos and publications, as well as overviews of social media channels and mobile apps of the Bayer Group.
NEUROTRACKER CUSTOMIZE SOFTWARE CODE